Predictive data mining in clinical medicine: current issues and guidelines
R Bellazzi, B Zupan - International journal of medical informatics, 2008 - Elsevier
BACKGROUND: The widespread availability of new computational methods and tools for
data analysis and predictive modeling requires medical informatics researchers and …
data analysis and predictive modeling requires medical informatics researchers and …
The multifaceted role of Notch in cancer
M Roy, WS Pear, JC Aster - Current opinion in genetics & development, 2007 - Elsevier
The diverse roles that Notch signals play during the development and maintenance of
normal tissues are recapitulated in different forms of cancer. Depending on the tumor type …
normal tissues are recapitulated in different forms of cancer. Depending on the tumor type …
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy
Purpose Clinicopathologic features and biochemical recurrence are sensitive, but not
specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a …
specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a …
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
UR Chandran, C Ma, R Dhir, M Bisceglia… - BMC cancer, 2007 - Springer
Background Prostate cancer is characterized by heterogeneity in the clinical course that
often does not correlate with morphologic features of the tumor. Metastasis reflects the most …
often does not correlate with morphologic features of the tumor. Metastasis reflects the most …
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion
S Perner, JM Mosquera, F Demichelis… - The American journal …, 2007 - journals.lww.com
Prostate cancer (PCA) is one of the most prevalent cancers and a major leading cause of
morbidity and mortality in the Western world. The TMPRSS2-ERG fusion was recently …
morbidity and mortality in the Western world. The TMPRSS2-ERG fusion was recently …
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer
Background Hypoxia is associated with a poor prognosis in prostate cancer. This work
aimed to derive and validate a hypoxia-related mRNA signature for localized prostate …
aimed to derive and validate a hypoxia-related mRNA signature for localized prostate …
Active surveillance for early‐stage prostate cancer: review of the current literature
MA Dall'Era, MR Cooperberg, JM Chan… - … Journal of the …, 2008 - Wiley Online Library
The natural history of prostate cancer is remarkably heterogeneous and, at this time, not
completely understood. The widespread adoption and application of prostate‐specific …
completely understood. The widespread adoption and application of prostate‐specific …
Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
MM Mortensen, S Høyer, AS Lynnerup, TF Ørntoft… - Scientific reports, 2015 - nature.com
Prostate cancer is a leading cause of cancer death amongst males. The main clinical
dilemma in treating prostate cancer is the high number of indolent cases that confer a …
dilemma in treating prostate cancer is the high number of indolent cases that confer a …
Microenvironmental regulation of cancer stem cell phenotypes
DF Quail, MJ Taylor, LM Postovit - Current stem cell research …, 2012 - ingentaconnect.com
Cancer is a complex set of diseases, driven by genomic instability overlaid with epigenetic
modifications. Two prevailing concepts, the stochastic theory and the hierarchical theory, are …
modifications. Two prevailing concepts, the stochastic theory and the hierarchical theory, are …
Morphological features of TMPRSS2–ERG gene fusion prostate cancer
JM Mosquera, S Perner, F Demichelis… - The Journal of …, 2007 - Wiley Online Library
The TMPRSS2–ETS fusion prostate cancers comprise 50–70% of the prostate‐specific
antigen (PSA)‐screened hospital‐based prostate cancers examined to date, making it …
antigen (PSA)‐screened hospital‐based prostate cancers examined to date, making it …